← Leaderboards
Xinbin Chen
Medical College Of Georgia (Mcg)
$30,256,575
Attributed
$32,248,411
Total exposure
16
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,248,411 · 16
By mechanism
R01$27,687,186 · 11
T32$3,444,701 · 2
P30$840,797 · 2
R29$275,727 · 1
Top collaborators
- Robert J. Canter5 shared
- Michael Sean Kent5 shared
- Bethany Paige Cummings4 shared
- Isaac N Pessah2 shared
Most similar at Medical College Of Georgia (Mcg)
Same institution · by research overlap
- Darrell W Brann$7,395,259
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDna DamageTumor SuppressionTumorTumor Suppressor ProteinsTp53 GeneGenesApoptosisPathway InteractionsFamilyTumor ProgressionPlaySignal TransductionMemberRegulationMutantMediatingStressCellsBiologyProtein P53Neoplasm MetastasisCell Cycle ArrestResponse
Grant awards (118)
A novel therapeutic strategy to target mutant p53$590,625
R01 · FY2025 · CA · contact PI
The nuclear Ferredoxin reductase and its role in tumor suppression$479,793
R01 · FY2025 · CA · contact PI
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53$436,503
R01 · FY2025 · CA · contact PI
UC Davis DVM/PhD Medical Scientist Training Program$408,815
T32 · FY2025 · GM
Comparative Oncology Program$74,441
P30 · FY2025 · CA · contact PI
The nuclear Ferredoxin reductase and its role in tumor suppression$479,293
R01 · FY2024 · CA · contact PI
Mechanism of p53-dependent Tumor Suppression$433,586
R01 · FY2024 · CA · contact PI
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53$416,902
R01 · FY2024 · CA · contact PI
UC Davis DVM/PhD Medical Scientist Training Program$276,787
T32 · FY2024 · GM
UC Davis Comparative Oncology Training Program$124,734
T32 · FY2024 · CA · contact PI
Comparative Oncology Program$120,747
P30 · FY2024 · CA · contact PI
Mechanism of p53-dependent Tumor Suppression$444,566
R01 · FY2023 · CA · contact PI
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53$431,473
R01 · FY2023 · CA · contact PI
UC Davis DVM/PhD Medical Scientist Training Program$329,067
T32 · FY2023 · GM
UC Davis Comparative Oncology Training Program$290,518
T32 · FY2023 · CA · contact PI
Comparative Oncology Program$120,660
P30 · FY2023 · CA · contact PI
Mechanism of P73-dependent Tumor Suppression$443,116
R01 · FY2022 · CA · contact PI
Mechanism of p53-dependent Tumor Suppression$442,977
R01 · FY2022 · CA · contact PI
The Mechanism and Therapeutic Potential of Targeting the Ninjurin Pathway for Tumors Carrying Wild-Type p53$438,940
R01 · FY2022 · CA · contact PI
UC Davis Comparative Oncology Training Program$429,080
T32 · FY2022 · CA · contact PI
The feedback loop between ferredoxin reductase and the p53 family in tumor suppression$383,645
R01 · FY2022 · CA · contact PI
UC Davis DVM/PhD Medical Scientist Training Program$322,963
T32 · FY2022 · GM
Comparative Oncology Program$120,283
P30 · FY2022 · CA · contact PI
Mechanism of p53-dependent Tumor Suppression$459,133
R01 · FY2021 · CA · contact PI
Mechanism of P73-dependent Tumor Suppression$452,162
R01 · FY2021 · CA · contact PI
UC Davis Comparative Oncology Training Program$434,033
T32 · FY2021 · CA · contact PI
The feedback loop between ferredoxin reductase and the p53 family in tumor suppression$401,121
R01 · FY2021 · CA · contact PI
UC Davis DVM/PhD Medical Scientist Training Program$240,174
T32 · FY2021 · GM · contact PI
Comparative Oncology Program$118,398
P30 · FY2021 · CA · contact PI
Mechanism of p53-dependent Tumor Suppression$461,263
R01 · FY2020 · CA · contact PI
Mechanism of P73-dependent Tumor Suppression$452,162
R01 · FY2020 · CA · contact PI
The feedback loop between ferredoxin reductase and the p53 family in tumor suppression$410,152
R01 · FY2020 · CA · contact PI
The role of the p63-RBM38 loop in tumor suppression$359,138
R01 · FY2020 · CA · contact PI
UC Davis Comparative Oncology Training Program$338,546
T32 · FY2020 · CA · contact PI
UC Davis DVM/PhD Medical Scientist Training Program$249,984
T32 · FY2020 · GM · contact PI
Comparative Oncology Program$49,243
P30 · FY2020 · CA · contact PI
Mechanism of P73-dependent Tumor Suppression$438,596
R01 · FY2019 · CA · contact PI
The feedback loop between ferredoxin reductase and the p53 family in tumor suppression$408,073
R01 · FY2019 · CA · contact PI
The role of the p63-RBM38 loop in tumor suppression$348,363
R01 · FY2019 · CA · contact PI
Comparative Oncology Program$49,243
P30 · FY2019 · CA · contact PI
Mechanism of P73-dependent Tumor Suppression$452,160
R01 · FY2018 · CA · contact PI
The feedback loop between ferredoxin reductase and the p53 family in tumor suppression$439,570
R01 · FY2018 · CA · contact PI
The role of the p63-RBM38 loop in tumor suppression$359,138
R01 · FY2018 · CA · contact PI
Comparative Oncology Program$41,297
P30 · FY2018 · CA · contact PI
Comparative Oncology Program$12,500
P30 · FY2018 · CA · contact PI
Comparative Oncology Program$11,775
P30 · FY2018 · CA · contact PI
Comparative Oncology Program$10,000
P30 · FY2018 · CA · contact PI
Comparative Oncology Program$6,250
P30 · FY2018 · CA · contact PI
Comparative Oncology Program$4,474
P30 · FY2018 · CA · contact PI
Comparative Oncology Program$3,000
P30 · FY2018 · CA · contact PI
The role of the p63-RBM38 loop in tumor suppression$359,138
R01 · FY2017 · CA · contact PI
Mechanism of p53-dependent tumor suppression$300,867
R01 · FY2017 · CA · contact PI
Comparative Oncology Program$49,243
P30 · FY2017 · CA · contact PI
The role of the p63-RBM38 loop in tumor suppression$358,852
R01 · FY2016 · CA · contact PI
Mechanism of p53-dependent tumor suppression$300,867
R01 · FY2016 · CA · contact PI
Regulation of Mutant P53 Expression and Oncogenic Activity$282,901
R01 · FY2016 · CA · contact PI
Comparative Oncology Program$49,243
P30 · FY2016 · CA · contact PI
Mechanism of P73-Dependent Tumor Suppression$304,560
R01 · FY2015 · CA · contact PI
Mechanism of p53-dependent tumor suppression$300,867
R01 · FY2015 · CA · contact PI
Regulation of Mutant P53 Expression and Oncogenic Activity$282,901
R01 · FY2015 · CA · contact PI
Mechanism of P73-Dependent Tumor Suppression$295,423
R01 · FY2014 · CA · contact PI
Mechanism of p53-dependent tumor suppression$291,841
R01 · FY2014 · CA · contact PI
Regulation of Mutant P53 Expression and Oncogenic Activity$274,414
R01 · FY2014 · CA · contact PI
The role of DNA polymerase eta in DNA damage response and p53 activation$270,599
R01 · FY2014 · CA · contact PI
Mechanism of p53-dependent tumor suppression$300,867
R01 · FY2013 · CA · contact PI
Mechanism of P73-Dependent Tumor Suppression$286,286
R01 · FY2013 · CA · contact PI
Regulation of Mutant P53 Expression and Oncogenic Activity$265,998
R01 · FY2013 · CA · contact PI
The role of DNA polymerase eta in DNA damage response and p53 activation$262,230
R01 · FY2013 · CA · contact PI
Mechanism of P73-Dependent Tumor Suppression$304,395
R01 · FY2012 · CA · contact PI
Mechanism of p53-Mediated Tumor Suppression$296,959
R01 · FY2012 · CA · contact PI
Mechanism of p63-Dependent Tumor Suppression$288,347
R01 · FY2012 · CA · contact PI
Regulation of Mutant P53 Expression and Oncogenic Activity$283,822
R01 · FY2012 · CA · contact PI
The role of DNA polymerase eta in DNA damage response and p53 activation$278,590
R01 · FY2012 · CA · contact PI
Mechanism of P73-Dependent Tumor Suppression$303,406
R01 · FY2011 · CA · contact PI
Mechanism of p53-Mediated Tumor Suppression$296,959
R01 · FY2011 · CA · contact PI
Mechanism of p63-Dependent Tumor Suppression$288,347
R01 · FY2011 · CA · contact PI
Molecular Oncogenic Properties of Mutant p53$280,136
R01 · FY2011 · CA · contact PI
The role of DNA polymerase eta in DNA damage response and p53 activation$277,684
R01 · FY2011 · CA · contact PI
Mechanism of p53-Mediated Tumor Suppression$306,143
R01 · FY2010 · CA · contact PI
Mechanism of P73-Dependent Tumor Suppression$303,406
R01 · FY2010 · CA · contact PI
Mechanism of p63-Dependent Tumor Suppression$297,265
R01 · FY2010 · CA · contact PI
Molecular Oncogenic Properties of Mutant p53$288,800
R01 · FY2010 · CA · contact PI
The role of DNA polymerase eta in DNA damage response and p53 activation$285,728
R01 · FY2010 · CA · contact PI
Mechanism of p53-Mediated Tumor Suppression$306,143
R01 · FY2009 · CA · contact PI
Mechanism of P73-Dependent Tumor Suppression$302,253
R01 · FY2009 · CA · contact PI
Mechanism of p63-Dependent Tumor Suppression$297,265
R01 · FY2009 · CA · contact PI
Molecular Oncogenic Properties of Mutant p53$288,800
R01 · FY2009 · CA · contact PI
Mechanism of p53-Mediated Tumor Suppression$306,143
R01 · FY2008 · CA · contact PI
Mechanism of p63-Dependent Tumor Suppression$297,265
R01 · FY2008 · CA · contact PI
Mechanism of p73-dependent tumor suppression$291,851
R01 · FY2008 · CA · contact PI
Molecular Oncogenic Properties of Mutant p53$288,800
R01 · FY2008 · CA · contact PI
Mechanism of p73-dependent tumor suppression$291,531
R01 · FY2007 · CA · contact PI
The transcriptional activity of p63, a p53 family member$288,607
R01 · FY2007 · CA · contact PI
Molecular Oncogenic Properties of Mutant p53$288,481
R01 · FY2007 · CA · contact PI
Molecular Oncogenic Properties of Mutant p53$1
R01 · FY2007 · CA · contact PI
Mechanism of p53-Mediated Tumor Suppression$296,328
R01 · FY2006 · CA · contact PI
Mechanism of p73-dependent tumor suppression$286,724
R01 · FY2006 · CA · contact PI
The transcriptional activity of p63, a p53 family member$176,758
R01 · FY2006 · CA · contact PI
The transcriptional activity of p63, a p53 family member$109,133
R01 · FY2006 · CA · contact PI
Mechanism of p53-Mediated Tumor Suppression$1
R01 · FY2006 · CA · contact PI
Mechanism of p73-dependent tumor suppression$293,625
R01 · FY2005 · CA
The transcriptional activity of p63, a p53 family member$290,363
R01 · FY2005 · CA
Mechanism of p53-Mediated Tumor Suppression$290,363
R01 · FY2005 · CA
Mechanism of p73-dependent tumor suppression$293,625
R01 · FY2004 · CA
The transcriptional activity of p63, a p53 family member$290,363
R01 · FY2004 · CA
Mechanism of p53-Mediated Tumor Suppression$290,363
R01 · FY2004 · CA
Mechanism of p53-Mediated Tumor Suppression$290,363
R01 · FY2003 · CA
The transcriptional activity of p63, a p53 family member$290,363
R01 · FY2003 · CA
MECHANISM OF P73 DEPENDENT TUMOR SUPPRESSION$251,788
R01 · FY2003 · CA
Mechanism of p53-Mediated Tumor Suppression$290,196
R01 · FY2002 · CA
MECHANISM OF P73 DEPENDENT TUMOR SUPPRESSION$242,736
R01 · FY2002 · CA
MECHANISM OF P53 DEPENDENT APOPTOSIS$71,327
R29 · FY2002 · CA
MECHANISM OF P73 DEPENDENT TUMOR SUPPRESSION$172,735
R01 · FY2001 · CA
MECHANISM OF P53 DEPENDENT APOPTOSIS$83,394
R29 · FY2001 · CA
MECHANISM OF P73 DEPENDENT TUMOR SUPPRESSION$68,734
R01 · FY2001 · CA
MECHANISM OF P53 DEPENDENT APOPTOSIS$18,806
R29 · FY2001 · CA
MECHANISM OF P73 DEPENDENT TUMOR SUPPRESSION$234,437
R01 · FY2000 · CA
MECHANISM OF P53 DEPENDENT APOPTOSIS$102,200
R29 · FY2000 · CA